![[CALL FOR INITIATIVES] - Successful candidates 2026](https://static.wixstatic.com/media/nsplsh_6e47324d3458636b457949~mv2_d_5184_3456_s_4_2.jpg/v1/fill/w_1500,h_1000,fp_0.50_0.50,q_30,blur_30,enc_avif,quality_auto/nsplsh_6e47324d3458636b457949~mv2_d_5184_3456_s_4_2.jpg)
![[CALL FOR INITIATIVES] - Successful candidates 2026](https://static.wixstatic.com/media/nsplsh_6e47324d3458636b457949~mv2_d_5184_3456_s_4_2.jpg/v1/fill/w_408,h_272,fp_0.50_0.50,q_90,enc_avif,quality_auto/nsplsh_6e47324d3458636b457949~mv2_d_5184_3456_s_4_2.jpg)
![[SUMMARY & OUTCOME] From UNOC-3 to COP31: Science Evidence, Pacific Resilience and Southern Connections](https://static.wixstatic.com/media/d57139_0f320a54a87a4cb29db22dfea46cad8d~mv2.jpg/v1/fill/w_1500,h_1000,fp_0.50_0.50,q_30,blur_30,enc_avif,quality_auto/d57139_0f320a54a87a4cb29db22dfea46cad8d~mv2.jpg)
![[SUMMARY & OUTCOME] From UNOC-3 to COP31: Science Evidence, Pacific Resilience and Southern Connections](https://static.wixstatic.com/media/d57139_0f320a54a87a4cb29db22dfea46cad8d~mv2.jpg/v1/fill/w_408,h_272,fp_0.50_0.50,q_90,enc_avif,quality_auto/d57139_0f320a54a87a4cb29db22dfea46cad8d~mv2.jpg)
![[OPPORTUNITY] Pacific Funds 2027 is now open to application](https://static.wixstatic.com/media/d57139_0766fdc99b47407f9ed70afdf9f20d4f~mv2.png/v1/fill/w_1005,h_591,fp_0.50_0.50,q_35,blur_30,enc_avif,quality_auto/d57139_0766fdc99b47407f9ed70afdf9f20d4f~mv2.png)
![[OPPORTUNITY] Pacific Funds 2027 is now open to application](https://static.wixstatic.com/media/d57139_0766fdc99b47407f9ed70afdf9f20d4f~mv2.png/v1/fill/w_408,h_240,fp_0.50_0.50,q_95,enc_avif,quality_auto/d57139_0766fdc99b47407f9ed70afdf9f20d4f~mv2.png)
PhD offer in tumor immunology
Sep 17, 2021
1 min read
Role of B cells and plasma cell subsets in tumor immune surveillance through a comprehensive exploration of tumors associated with paraneoplastic syndromes (PNS)
A PhD position is available within the team “Cancer Immune Surveillance and Therapeutic Targeting” (CISTAR) from the Cancer Research Center of Lyon (CRCL, www.crcl.fr). Interested candidates should submit a motivation letter, CV, master 2 marks and ranking with contact details of 1 or 2 references to Bertrand Dubois (Bertrand.dubois@lyon.unicancer.fr) before October 1st 2021.
Comments